{"organizations": [], "uuid": "f0917311cf92d1b172b83a100bfdecca99477226", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "uk.finance.yahoo.com", "main_image": "https://s.yimg.com/bt/api/res/1.2/6rik6AZwuPGCiADf_9dhPQ--/YXBwaWQ9eW5ld3M7cT03NTt3PTYwMA--/http://l.yimg.com/os/mit/media/m/social/images/social_default_logo-1481777.png", "site_section": "https://uk.finance.yahoo.com/news/sector-basic-materials/?format=rss", "section_title": "Basic Resources News | Yahoo! Finance", "url": "https://uk.finance.yahoo.com/news/company-profile-merganser-biotech-144000465.html", "country": "US", "title": "Company Profile for Merganser Biotech", "performance_score": 0, "site": "yahoo.com", "participants_count": 0, "title_full": "Company Profile for Merganser Biotech", "spam_score": 0.0, "site_type": "news", "published": "2015-08-21T17:40:00.000+03:00", "replies_count": 0, "uuid": "f0917311cf92d1b172b83a100bfdecca99477226"}, "author": "", "url": "https://uk.finance.yahoo.com/news/company-profile-merganser-biotech-144000465.html", "ord_in_thread": 0, "title": "Company Profile for Merganser Biotech", "locations": [], "entities": {"persons": [], "locations": [], "organizations": []}, "highlightText": "", "language": "english", "persons": [], "text": "Tip : Use comma (,) to separate multiple quotes. Learn more... \nFri, Aug 21, 2015, 16:03 BST - UK Markets close in 27 mins. Company Profile for Merganser Biotech Press Release : Merganser Biotech – 23 minutes ago Print Related Content \nMerganser Biotech is a privately funded biotech company focused on the evaluation of hepcidin mimetic peptides for the treatment of rare hematological and iron overload diseases. Target indications for lead compound (M012) include Beta Thalassemia, Polycythemia Vera, Hemochromatosis and Acute Sever Infections caused by siderophilic pathogens in patients with iron overload. Merganser Biotech is backed by a syndicate of life sciences investors that includes the Novartis Venture Fund, Frazier Healthcare Partners, Sutter Hill Ventures and Osage University Partners. King of Prussia, PA 19406 Follow the quotes you care about most. Access timely news and investment updates to stay on top of the market. … More » Yahoo UK & Ireland Finance Terms \nQuotes are real-time for NASDAQ, NYSE, and NYSEAmex when available. See also delay times for other exchanges . Quotes and other information supplied by independent providers identified on the Yahoo! Finance partner page . Quotes are updated automatically, but will be turned off after 25 minutes of inactivity. Quotes are delayed at least 15 minutes. All information provided \"as is\" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein. \nFundamental company data provided by Capital IQ . Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI) . International historical chart data and daily updates provided by Morningstar, Inc . Yahoo! - News Network", "external_links": [], "published": "2015-08-21T17:40:00.000+03:00", "crawled": "2015-08-21T18:05:39.796+03:00", "highlightTitle": ""}